BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1168 related articles for article (PubMed ID: 18772170)

  • 1. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M
    Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
    Motohara T; Ozawa Z; Morita S
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
    Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
    Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
    Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein.
    Itamoto T; Nakahara H; Tashiro H; Haruta N; Asahara T; Naito A; Ito K
    J Surg Oncol; 2002 Jul; 80(3):143-8. PubMed ID: 12115797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic arterial infusion chemotherapy (HAI) for advanced hepatocellular carcinoma inefficacious with transcatheter arterial embolization (TAE)].
    Takayama W; Asano T; Kobayashi S; Nakagouri S; Kenmochi T; Okazumi S; Takeda A; Fukunaga T; Iwasaki K; Shutou K; Matsuzaki H; Aoyama H; Shinotou K; Kouno T; Isono K
    Gan To Kagaku Ryoho; 1998 May; 25(6):867-71. PubMed ID: 9617325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
    Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoembolization and regional hyperthermia with degradable starch microspheres in the treatment of malignant hepatic tumors].
    Yoshikawa T; Oyamada H; Itani K; Tainaka K; Seto O; Sugino S; Kondo M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2646-52. PubMed ID: 2843131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
    Shimizu J; Nagano H; Sakon M; Dono K; Takeda Y; Kishimoto S; Eguchi H; Miyamoto A; Kondo M; Nakamori S; Umeshita K; Nakamura H; Wakasa K; Monden M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1895-9. PubMed ID: 10560420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
    Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.